Pim P. van de Donk - Concepedia

Author

Pim P. van de Donk

Also Known As

P.P. van de Donk, Pim P van de Donk, Pim P. van de Donk

Publications

445

Citations

H-Index

Concepts

All Affiliations

Pim P. van de Donk is an author at University Medical Center Groningen specializing in oncology, cancer therapeutics, and molecular oncology.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	2	2	44
2	Medicine	2	2	44
3	Cancer Therapeutics	2	2	44
4	Immunology	1	1	11
5	Pathology	1	1	11

Pim P. van de Donk

Publications

286

Citations

H-Index

Page 1

	Year	Citations
Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial Laura Kist de Ruijter, Pim P. van de Donk, Jahlisa S. Hooiveld-Noeken, Nature Medicine	2022	112
89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer Iris C. Kok, J.S. Hooiveld, Pim P. van de Donk, Annals of Oncology	2021	84
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy Pim P. van de Donk, Thijs T. Wind, Jahlisa S. Hooiveld-Noeken, European Journal of Nuclear Medicine and Molecular Imaging	2021	46
<sup>89</sup>Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer Sarah R. Verhoeff, Pim P. van de Donk, Erik H.J.G. Aarntzen, Journal of Nuclear Medicine Neck CancerOncologic ImagingPd-l1 ExpressionMedicinePd-l1 Imaging	2022	33
<sup>89</sup>Zr-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck. Sarah R. Verhoeff, Pim P. van de Donk, Erik H.J.G. Aarntzen, Journal of Clinical Oncology Oncologic ImagingSquamous Cell CarcinomaImmunologyPathologyImmunotherapeutics	2020	11

Page 1